Rank #1841BNR

Burning Rock Biotech Limited

$29.92

-0.23% (Daily)

Market Cap

$322.14M

Revenue

$539.28M

Rank by MCap

#1841

Sector

Healthcare

Industry

Diagnostics & Research

CEO

Mr. Yusheng Han

Headquarters

Guangzhou

Employees

674

About Burning Rock Biotech Limited

Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company offers next-generation sequencing (NGS)-based tissue, liquid biopsy cancer therapy selection, and prognosis prediction tests for various cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breas...